Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway

Journal of Cellular Physiology

Volumn 207, Issue 3, 2006, Pages 729-734

  Kuo, Lunyu ^a   Chang, Hui Chiu ^b   Leu, Tzeng Horng ^c   Maa, Ming Chie ^d   Hung, Wen Chun ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR SP1; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; ELECTROPHORESIS; FIBROBLAST CULTURE; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; BINDING SITES; CELL LINE; FLAVONOIDS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

ANIMALIA; MURINAE;

EID: 33646357488     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20616     Document Type: Article

References (36)

1. Birkedal-Hansen H. 1995. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735.
2. Bonello MR, Khachigian LM. 2004. Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/ 2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter. J Biol Chem 279:2377-2382.
3. Brabek J, Constancio SS, Shin NY, Pozzi A, Weaver AM, Hanks SK. 2004. CAS promotes invasiveness of Src-transformed cells. Oncogene 23:7406-7415.
4. Brabek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, Hanks SK. 2005. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of Src-transformed cells. Mol Cancer Res 3:307-315.
5. Brinckerhoff CE, Rutter JL, Benbow U. 2000. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6:4823-4830.
6. Brown MT, Cooper JA. 1996. Regulation, substrates and functions of src. Biochem Biophys Acta 1287:121-149.
7. Chang HC, Liu LT, Hung WC. 2004. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cell Signal 16: 675-679.
8. Chen HC, Feener EP. 2004. MEK1.2 response element mediates angiotensin II-stimulated plasminogen activator inhibitor-1 promoter activation. Blood 103: 2636-2644.
9. Chen JM, Aimes RT, Ward GR, Youngleib CL, Quigley JP. 1991. Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J Biol Chem 266: 5113-5121.
10. Duffy MJ. 1996. Proteases as prognostic markers in cancer. Clin Cancer Res 2: 613-618.
11. Hauck CR, Hsia DA, Puente XS, Cheresh DA, Schlaepfer DD. 2002. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J 21:6289-6302.
12. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA, Schlaepfer DD. 2003. Differential regulation of cell motility and invasion by FAK. J Cell Biol 160: 753-767.
13. Kurata H, Thant AA, Matsuo S, Senga T, Okazaki K, Hotta N, Hamguchi M. 2000. Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. Exp Cell Res 254:180-188.
14. Lee TH, Chuang LY, Hung WC. 2000. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 19:3766-3773.
15. Liu LT, Chang HC, Chiang LC, Hung WC. 2003. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 63:3069-3072.
16. Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ. 1995. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers. Proc Natl Acad Sci USA 92: 6981-6985.
17. Matsuda M, Mayer BJ, Fukui Y, Hanafusa H. 1990. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537-1539.
18. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M. 1992. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118:703-714.
19. Merchant JL, Du M, Todisco A. 1999. Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 254:454-461.
20. Milanini-Mongiat J, Pouyssegur J, Pages G. 2002. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639.
21. Miyamori H, Hasegawa K, Kim KR, Sato H. 2000. Expression of metastasis-associated mts1 gene is co-induced with membrane type-1 matrix metalloproteinase (MT1-MMP) during oncogenic transformation and tubular formation of Madin Darby canine kidney (MDCK) epithelial cells. Clin Exp Metastasis 18: 51-56.
22. Noritake H, Miyamori H, Goto C, Seiki M, Sato H. 1999. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src. Clin Exp Metastasis 17:105-110.
23. Pan MR, Hung WC. 2002. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem 277:32775-32780.
24. Qin H, Sun Y, Benveniste EN. 1999. The transcription factors Sp1, SpS, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274:29130-29137.
25. Reynolds AB, Kanner SB, Wang HC, Parsons JT. 1989. Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins. Mol Cell Biol 9:3951-3958.
26. Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Gepper TD, Cobb MH. 1993. Regulation of properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 288:5097-5106.
27. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H. 1994. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 13: 3748-3756.
28. Sato H, Kita M, Seiki M. 1993. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 268:23460-23468.
29. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
30. Summy JM, Gallick GE. 2003. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22:337-358.
31. Thant AA, Sein TT, Liu E, Machida K, Kikkawa F, Koike T, Seiki M, Matsuda S, Hamaguchi M. 1999. Ras pathway is required for the activation of MMP-2 secretion and for the invasion of src-transformed 3Y1. Oncogene 18:6555-6563.
32. Trisciuoglio D, Iervolino A, Candiloro A, Fibbi G, Fanciulli M, Zangemeister-Wittke U, Zupi G, Del Bufalo D. 2004. bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: Involvement of ERK1/ERK2 activity. J Biol Chem 279:6737-6745.
33. Vincenti MP, Coon CI, White LA, Barchowsky A, Brinckerhofff CE. 1996. Src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts. Arthritis Rheum 39:574-582.
34. Vincenti MP, Schroen DJ, Coon CI, Brinckerhoff CE. 1998. v-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: Requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors. Mol Carcinog 21:194-204.
35. Warmuth M, Damoiseaux R, Liu Y, Fabbro D, Gray N. 2003. SRC family kinases: Potential targets for the treatment of human cancer and leukemia. Curr Pharm Des 9:2043-2059.
36. Yeatman TJ. 2004. A renaissance for SRC. Nat Rev Cancer 4:470-480.